Our company's strict production management and excellent product quality are favored by customers, our orders are in an endless stream and our CAS:137234-62-9, CAS:70500-72-0, 4-(MethylaMino)-3-nitrobenzoic acid sold all over the world. We have a large-scale production base. We follow the quality policy of 'quality first, dedicated service, and strive for excellence', and uphold the business philosophy of 'pragmatic innovation, continuous self-improvement, courage, integrity management, and people-oriented'.
This Anagliptin API CAS:739366-20-2 is a pharmaceuticadrus for the treatment of type 2 diabetes mellitus. It is approved for use in Japan. The product belongs to the class of anti-diabetic drues known as dipeptidyl peptidase-4 inhibitors. It is a white to yellow crystalline powder. The product' s purity is high, and its stability is good. Anagliptin has a positive effect on low density lipoprotein levels and is effective in assisting the treatment of type 2 diabetes
This Anagliptin API CAS:739366-20-2 has a broad medical market value. Since we have perfect production quality system, advanced equipment and rigorous scientific research attitude. The quality of the products is excellent and our company can offer long-term supply to you. If you are interested, please feel free to contact us and we will offer you the best service.
With strong technical strength, supply and marketing capabilities, our products are widely used in Ethylene Diamine Tetraacetic Acid (EDTA) CAS 60-00-4. We will continue to serve you as always, your patronage is our honor, and your suggestions are our strength for progress. We seek development in the market economy, and innovation in business development.